We recently published a list of 12 Best German Stocks to Buy According to Hedge Funds. In this article, we are going to take ...

BioNTech (NASDAQ:BNTX – Get Free Report) had its target price dropped by analysts at HC Wainwright from $150.00 to $145.00 in ...

We recently compiled a list of the 12 Most Promising Biotech Stocks According to Wall Street Analysts. In this article, we ...

In trading on Tuesday, shares of BioNTech SE (Symbol: BNTX) entered into oversold territory, hitting an RSI reading of 29.3, after changing hands as low as $87.605 per share. By comparison ...

Truist Financial analyst Asthika Goonewardene maintained a Buy rating on BioNTech SE (BNTX – Research Report) today. The company’s shares ...

BioNTech SE (NASDAQ:BNTX – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the eighteen brokerages that are covering the company, MarketBeat.com reports. Three research ...

The pharma and biotech sector has been under pressure since Donald Trump returned to the White House earlier this year.

The general mood among these heavyweight investors is divided, with 25% leaning bullish and 62% bearish. Among these notable ...

Among the largest underlying components of FNDF, in trading today Medtronic PLC (Symbol: MDT) is up about 1.3%, BioNTech SE (Symbol: BNTX) is down about 6.9%, and Ferguson Enterprises Inc (Symbol ...

Goldman Sachs analyst Chris Shibutani maintained a Buy rating on BioNTech SE (BNTX – Research Report) today and set a price target of $136.00.

In this article, we are going to look at where BioNTech SE (NASDAQ:BNTX) stands against other biotech stocks. The biotechnology sector is gaining new momentum with better market conditions ...